Optimization of topical therapy for Leishmania major localized cutaneous leishmaniasis using a reliable C57BL/6 Model.
Abstract
Pseudomonas aeruginosa otochondritis complicating localized cutaneous leishmaniasis: prevention of mutilation by early antibiotic therapy.
Abstract
AA-amyloidosis caused by visceral leishmaniasis in a human immunodeficiency virus-infected patient.
Abstract
WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: a phase 2, randomized, double blind, placebo controlled study.
Abstract
Topical paromomycin with or without gentamicin for cutaneous leishmaniasis.
Abstract
Clinical aspects and management of cutaneous leishmaniasis in rheumatoid patients treated with TNF-α antagonists.
Abstract
Parasite load decrease during application of a safe and easily applied antileishmanial aminoglycoside cream.
Abstract
Easy identification of leishmania species by mass spectrometry.
Abstract
Spontaneous remission of fully symptomatic visceral leishmaniasis.
Abstract
Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea.
Abstract